Novel drug extends breast cancer controlKinase inhibitor looks promising in phase II trial Chemo-plus-surgery trial shows more is betterAdjuvant therapy needed after surgery for local recurrence Trastuzumab: The gift that keeps on giving Breast cancer benefits continue to grow after treatment Adverse Reactions: Calcitonin and cancer risk Health Canada reviewing European recommendations that restrict use of calcitonin because of evidence suggesting an increased risk of cancer. The latest in targeted tumour therapy: Aspirin Study suggests ASA helps treat certain forms of colorectal cancer Colonoscopy: Is more frequent screening better? Study suggests average-risk men get scoped every four to six years Cancer gene testing gets speedier Faster test results will influence cancer treatment decision- making, B.C. doctor says Breast cancer care: It depends where you practise Report uncovers variations in diagnosis and treatment across Canada Rising PSA: Intermittent hormone deprivation as good as continuous Pauses in prostate cancer treatment give patients relief from side-effects Targeted agents tackle metastatic melanoma Two-drug combo looks promising in phase II trial First Previous 38 39 40 41 42 Next Last